Epclusa combination tablets, containing Sovosbuvir/velpatasvir, are an antiviral medication used to treat chronic hepatitis C virus (HCV) infection across all genotypes (1-6) in adults. This medication, manufactured by Gilead Sciences, is available as 1 tablet and has a YJ code of 6250116F1025.
Epclusa combination tablets
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
More from this manufacturer
